The blood-brain barrier (BBB) facilitates amyloid-b (Ab) exchange between the blood and the brain. Here, we found that the cellular prion protein (PrP c ), a putative receptor implicated in mediating Ab neurotoxicity in Alzheimer's disease (AD), participates in Ab transcytosis across the BBB. Using an in vitro BBB model, [ 125 I]-Ab 1À40 transcytosis was reduced by genetic knockout of PrP c or after addition of a competing PrP c -specific antibody. Furthermore, we provide evidence that PrP c is expressed in endothelial cells and, that monomeric Ab 1À40 binds to PrP c . These observations provide new mechanistic insights into the role of PrP c in AD.
Introduction
Alzheimer's disease (AD) is an incurable neurodegenerative disorder that is characterized by the accumulation of neurotoxic amyloid-b (Ab) peptides in the brain and intraneuronal hyperphosphorylation of the cytoskeletal protein tau (Selkoe, 2011) . Clinically, these cerebral manifestations result in memory impairment. Recent evidence suggests that the cellular prion protein (PrP c ) can mediate Ab 1À42 oligomer-induced impairment of synaptic function and, furthermore, is required for spatial learning and memory deficits observed in an AD transgenic mouse model (Gimbel et al, 2010; Lauren et al, 2009 ). However, these results were challenged recently (Balducci et al, 2010) .
Cellular prion protein is a glycosyl phosphatidylinositol (GPI)-anchored cell surface protein. Hence, it might require a transmembrane coreceptor to transduce signals into the cell that finally cause Ab-induced neurodegenerative phenotypes (Lauren et al, 2009 ). To date this coreceptor has not been identified but a previous report showed that the low density lipoprotein receptor-related protein 1 (LRP1) is capable of internalizing PrP c (Taylor and Hooper, 2007) . In addition, LRP1 participates in Ab 1À40 clearance across the bloodbrain barrier (BBB) by means of transcytosis (Pflanzner et al, 2011; Shibata et al, 2000; Zlokovic, 2008) . Interestingly, LRP1 binds Ab 1À40 with a much higher affinity than Ab 1À42 , resulting in greater LRP1-dependent Ab 1À40 internalization rates in endothelial cells (ECs) (Deane et al, 2004) . Based on the observation that Ab binds to PrP c , we set out to determine if LRP1's ability to internalize PrP c has a pathophysiological role in AD pathogenesis at the BBB. By using an in vitro transwell model of the BBB consisting of primary mouse brain capillary ECs (pMBCECs), we were able to show that PrP c is required for Ab 1À40 transcytosis across the BBB.
Materials and methods

Primary Mouse Brain Capillary Endothelial Cell Transwell Transport Model
Isolation and cultivation of pMBCECs have been previously described (Pflanzner et al, 2011) , and are provided as Supplementary Information.
Amyloid-b transcytosis across pMBCEC monolayers was investigated after inducing high transendothelial electrical resistance. Then, 0.1 nM [ 125 I]-Ab 1À40 and 1 mCi/mL [ 14 C]inulin (both from Perkin-Elmer, Rodgau, Germany), the latter a marker for paracellular diffusion, were diluted in serum free DMEM/Ham's F12 medium (Gibco, Darmstadt, Germany) + 550 nM hydrocortisone (Sigma, Schnelldorf, Germany) + 20 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (Lonza, Cologne, Germany) and added to the donor compartment. To inhibit Ab binding to PrP c , mouse monoclonal anti-PrP c (Ab51.2) hybridoma supernatant was dialyzed against phosphate-buffered saline (PBS) over night at 41C and used at a final concentration of 2.25 mg/mL. For details on the generation and specificity of monoclonal 51.2 antibody detecting PrP c , please refer to Supplementary Information. Receptor-associated protein (RAP) was expressed in bacteria as a fusion protein with GST (glutathione S-transferase) and was purified as previously described (Martin et al, 2008) . RAP-GST, or GST as control, was used at 500 nM to block Ab binding to LRP1. Amyloid-b transport was studied for 2 hours in the brain to blood and for 6 hours in the blood to brain direction. From each input and at each time point, 10 and 50 mL samples were taken from the compartment the transport was investigated to (acceptor). In all, 10m L probes were counted on a Wallac Wizard 2 2470 automatic g-counter (Perkin-Elmer) for [ 125 I], or on a Tri-Carb 2800 TR Liquid Scintillation Analyzer (Perkin-Elmer) for [ 14 C]. To investigate the amount of intact [ 125 I]-Ab 1À40 being transported, 50 mL of a 15% trichloroacetic acid solution was added to a 50 mL media sample and incubated for 10 minutes at 41C before samples were centrifuged at 10,000 g for 10 minutes. Supernatant (free [ 125 I]) and pellet (intact [ 125 I]-Ab 1À40 ) were counted separately for [ 125 I]. Transport of intact [ 125 I]-Ab 1À40 across the monolayer was calculated as Ab 1À40 TQ (transcytosis quotient):
Results represent the mean + s.e.m. of three independent experiments in triplicate.
Coimmunoprecipitation, Sodium Dodecylsulfate-Polyacrylamide Gel, and Western Blot Analysis
For detailed information, please see Supplementary Information.
[ 125 I]-Ab 1À40 Binding Study
Recombinant PrP c (rPrP c ) was synthesized as previously described (Leliveld et al, 2008 
Statistics
All graphs and statistical analyses were prepared using GraphPad Prism 4 software (La Jolla, CA, USA). Data were analyzed by one-way analysis of variance coupled to Newman-Keuls posttest for multiple comparison or t-test. P < 0.05 was considered to be statistically significant.
Results
To determine whether PrP c participates in Ab transcytosis across the BBB, we investigated the transport of [ 125 I]-Ab 1À40 across an in vitro BBB transwell model consisting of pMBCECs. In the brain to blood (abluminal to luminal) direction, [ 125 I]-Ab 1À40 transcytosis was significantly reduced by the addition of a mouse monoclonal antibody against PrP c (Ab51.2; for details see Supplementary Information) to levels observed in pMBCECs generated from PrP c KO (knockout) animals ( Figure 1A ). Similar results were obtained when [ 125 I]-Ab 1À40 transcytosis was analyzed in the blood to brain direction ( Figure 1B) . LRP1 has been shown to mediate Ab transport across the BBB (Pflanzner et al, 2011) . However, we observed only a nonsignificantly different decrease in Ab transport rates when LRP1-mediated Ab transport was additionally inhibited by RAP (synthesized as GST fusion protein) ( Figure 1B) . To strengthen the participation of PrP c in Ab transcytosis across the BBB, we analyzed protein expression in pMBCECs. Immunoblotting revealed robust expression levels of PrP c in pMBCECs derived from wildtype (WT) animals, whereas LRP1 levels were comparable between pMBCECs prepared from WT and PrP c KO animals ( Figure 1C ). Moreover, we were able to demonstrate that LRP1 coimmunoprecipitates with the most abundant 27 kDa PrP c isoform present in pMBCECs ( Figures 1C and 1D) . Previous results demonstrated that PrP c binds Ab 1À42 oligomers and mediates oligomer-induced neuronal toxicity (Lauren et al, 2009); however, these findings are controversially discussed (Balducci et al, 2010) . Since we observed that PrP c has a role in the transcytosis of monomeric Ab 1À40 across the BBB, we set out to investigate whether PrP c indeed binds Ab 1À40 monomers. By using rPrP c , we provide evidence that rPrP c binds monomeric [ 125 I]-Ab 1À40 in the low picomolar range ( Figure 1E ).
Discussion
The BBB has an important role in the pathogenesis of AD by governing bidirectional transcytosis of neuro-toxic Ab, thereby, maintaining an Ab equilibrium that is likely critical to prevent accumulation and aggregation of Ab species in the brain. Several transmembrane receptors and transporters have been identified to have a role in Ab transport mechanisms at the BBB (Pflanzner et al, 2010; Zlokovic, 2008) , emphasizing the complexity and necessity of these exchanges.
The PrP c belongs to the family of GPI-anchored cell surface proteins. Its role in mediating Ab oligomerinduced neurotoxicity is not fully resolved due to the lack of intracellular motifs that enable signal transduction into the cell. Hence, it has been suggested that PrP c requires a transmembrane coreceptor to elicit, for example, synaptic dysfunction on Ab oligomer binding to PrP c (Lauren et al, 2009 ). To date, the low density LRP1 is the only transmembrane protein that has been shown to mediate PrP c internalization through clathrin-coated pits through interactions between the extracellular domains of both receptors (Shyng et al, 1994; Taylor and Hooper, 2007) . LRP1 endocytosis is facilitated through its cytosolic NPxYxxL motif (Li et al, 2000; Pflanzner et al, 2011) , a highly conserved domain that also functions in signal transduction (Martin et al, 2008) .
Genetic evidence supports that LRP1 mediates Ab 1À40 transcytosis across the BBB (Pflanzner et al, 2011) . Due to the fact that LRP1 is required for PrP c endocytosis (Taylor and Hooper, 2007) , we investigated whether PrP c is involved in Ab 1À40 transport across the BBB. Strikingly, on genetic deletion of PrP c , we found that Ab transcytosis in the brain to blood direction was reduced by B50% in our primary in vitro BBB model. In addition, a monoclonal antibody against PrP c diminished Ab transport to levels observed in PrP c -deficient endothelial monolayers ( Figure 1A) , indicating that the binding of monomeric Ab 1À40 to PrP c is required for Ab transcytosis across the BBB. To emphasize this novel role of PrP c , we analyzed the presence of PrP c in our primary ECs and tested whether monomeric Ab 1À40 binds to rPrP c . In contrast to ECs that were derived from PrP c KO animals, we found robust PrP c expression levels in freshly isolated ECs, whereas LRP1 levels were comparable between both genotypes ( Figure 1C ). This excluded the possibility that differences in Ab transport rates are due to altered LRP1 expression levels. Although previous efforts have focused on Ab 1À42 oligomer binding to PrP c (Lauren et al, 2009) , recent evidence supports that low molecular weight Ab 1À42 species also bind to PrP c (Calella et al, 2010) . In agreement with our transport studies, we demonstrate that Ab 1À40 monomers bind to rPrP c in the low picomolar range ( Figure 1E) . Therefore, the presence of PrP c in ECs, its binding capacity for monomeric Ab 1À40 , and the role in Ab 1À40 transcytosis across the BBB highlights an additional mechanism by which PrP c could influence AD pathogenesis.
Since PrP c does not contain intracellular motifs that facilitate receptor internalization, we investigated whether PrP c facilitated Ab 1À40 transport across the BBB might be coupled to LRP1-mediated Ab 1À40 transcytosis. We have previously shown that inhibition of ligand binding to LRP1 with RAP or knockin mutation of the NPxYxxL endocytosis motif reduces LRP1-mediated Ab 1À40 transcytosis across the BBB by B50% (Pflanzner et al, 2011) . Assuming that Ab transcytosis by LRP1 and PrP c occur independent of each other, RAP treatment should have a clear additional effect on Ab transcytosis compared with PrP c antibody alone. However, RAP did not further decrease Ab transport compared with anti-PrP c alone ( Figure 1B) . In line with this observation and LRP1's ability to internalize PrP c (Taylor and Hooper, 2007) , we therefore hypothesize that Ab 1À40 transcytosis across the BBB could occur through a mechanism in which both receptors cooperate to (1) increase the amount of available Ab-binding sites and (2) compensate for the lack of a functional endocytosis motif within PrP c , to enhance transcytosis efficiency. RAP treatment has been shown to interfere with both LRP1-mediated Ab transcytosis and PrP c endocytosis through clathrincoated pits in separate studies (Pflanzner et al, 2011; Taylor and Hooper, 2007) . Taken together, these findings suggest that the role of PrP c in Ab transcytosis across the BBB is potentially linked to LRP1. This is further emphasized by the fact that LRP1 coimmunoprecipitates with 27 kDa PrP c in vivo ( Figure 1D) , an isoform that is present on the cell surface although it is not glycosylated (Korth et al, 2000) . Transcytosis of cell surface proteins including LRP1 depends on the presence of tyrosine-based motifs (Anderson et al, 2005; Donoso et al, 2009) . Although these motifs are absent in some GPIanchored proteins such as PrP c , many GPI-anchored proteins are initially basolaterally sorted and then transcytosed to the apical membrane in polarized cells (Polishchuk et al, 2004) . Cellular prion protein has been detected in early endosomes (Magalhaes et al, 2002) , whereas one route of PrP c internalization has been demonstrated to be dependent on extracellular interactions with the endocytic receptor LRP1 (Taylor and Hooper, 2007) . Here, we provide evidence that PrP c facilitates Ab transcytosis across the BBB, conceivably in concert with LRP1, highlighting a novel role for PrP c in AD pathogenesis.
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